Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
FibroBiologics said it filed a Form 8-K with the SEC covering unregistered sales of equity and issuance of a debenture. The filing says the maximum number of shares issuable through conversion of the debenture is 1,671,094.
FibroBiologics said it filed a Form 8-K with the SEC covering direct or off-balance-sheet financial obligation.
FibroBiologics Inc. (FBLG) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 08, 2026. On October 7, 2026, FibroBiologics, Inc. (the "Company") entered into a securities purchase agreement (the "SPA") with Peak One Opportunity Fund, L.P. ("Peak One"), pursu
Fortune Brands Innovations filed a Form 3 naming Peter G. Clifford as EVP and CFO.
First Breach Inc. director Denean Rueben Williams reported 382,934 common shares held indirectly via WF Future LLC in an initial Form 3 filing.
FB Financial Corp files with SEC, disclosure pending review